Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation

Arthritis and Rheumatism

Volumn 42, Issue 9, 1999, Pages 1951-1960

  Decaris, Elvire ^a   Guingamp, Corinne ^a   Chat, Mireille ^a   Philippe, Lionel ^a   Grillasca, Joël Paul ^a   Abid, Amr ^a   Minn, Alain ^a   Gillet, Pierre ^a   Netter, Patrick ^a   Terlain, Bernard ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; INFLAMMATION; MALE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPINAL CORD COMPRESSION;

ANIMALS; ARTHRITIS, RHEUMATOID; FREUND'S ADJUVANT; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-6; KNEE JOINT; MALE; PROSTAGLANDINS; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; SUBSTANCE P; SYNAPTIC TRANSMISSION; TURPENTINE;

EID: 0033495842     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.0.CO;2-D     Document Type: Article

References (51)

1. Kidd BL, Mapp PI, Blake DR, Polak JM. Neurogenic influences in arthritis. Ann Rheum Dis 1990;49:649-52.
2. Thompson M, Bywaters EGL. Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962;21:370-7.
3. Segal R, Avrahami E, Lebdinski E, Habut B, Leibovitz A, Gil I, et al. The impact of hemiparalysis on the expression of osteoarthritis. Arthritis Rheum 1998;41:2249-56.
4. Glick EN. Asymmetrical rheumatoid arthritis after poliomyelitis. BMJ 1967;3:26-9.
5. Matucci-Cerinic M, McCarthy G, Lombardi A, Pignone A, Partsch G. Neurogenic influences in arthritis: potential modification by capsaicin. J Rheumatol 1995;22:1447-9.
6. Matucci-Cerinic M, Konttinen Y, Generini S, Cutolo M. Neuropeptides and steroid hormones in arthritis. Curr Opin Rheumatol 1998;10:220-35.
7. Singh VK. Neuropeptides as native immune modulators. Prog Drug Res 1995;45:9-15.
8. Turnbull AV, Pitossi FJ, Lebrun J-J, Lee S, Meltzer JC, Nance DM, et al. Inhibition of tumor necrosis factor-α action within the CNS markedly reduces the plasma adrenocorticotropin response to peripheral local inflammation in rats. J Neurosci 1997;17:3262-73.
9. Bileviciute I, Lundeberg T, Ekbolm A, Theodorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett 1993;153:37-40.
10. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A. Increased levels of substance P and calcitonin generelated peptide in rat adjuvant arthritis: a combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995; 38:699-709.
11. Amann R, Sirinathsinghji DJS, Donnerer J, Liebmann I, Schugoli R. Stimulation by nerve growth factor of neuropeptide synthesis in the adult rat in vivo: bilateral response to unilateral intraplantar injections. Neurosci Lett 1996;203:171-4.
12. Minami M, Kuraishi Y, Kawamura M, Yamaguchi T, Masu Y, Nakanishi S, et al. Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible involvement of substance P-containing spinal neurons in nociception. Neurosci Lett 1989;98:105-10.
13. Mapp PI, Terenghi G, Walsh DA, Chen ST, Cruwys SC, Garrett N, et al. Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience 1993;57:1091-6.
14. Leslie TA, Emson PC, Dowd PM, Woolf CJ. Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation. Neuroscience 1995; 67:753-61.
15. Berthelot JM, Glemarec J, Guillot P, Maugars Y, Prost A. Algodystrophy (reflex sympathetic dystrophy syndrome) and causalgia: novel concepts regarding the nosology, pathophysiology, and pathogenesis of complex regional pain syndromes: is the sympathetic hyperactivity hypothesis wrong? Rev Rhum Engl Ed 1997;64:481-91.
16. Dayer J-M, Burger D. Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw 1994;5:563-71.
17. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 1996;38:151-60.
18. Geisterfer M, Richards C, Baumann M, Fey G, Gwynne D, Gauldie J. Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. Cytokine 1993;5:1-7.
19. Gitter BD, Burns RF, Howbert JJ, Waters DC, Threlkeld PG, Cox LM, et al. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist. J Pharmacol Exp Ther 1995;275:737-44.
20. Radhakrishnan V, Iyengar S, Henry JL. The nonpeptide NK-1 receptor antagonists LY303870 and LY306740 block the responses of spinal horn neurons to substance P and to peripheral noxious stimuli. Neuroscience 1998;83:1251-60.
21. Cooper AL, Brouwer S, Turnbull AV, Luheshi GN, Hopkins SJ, Kunkel SL, et al. Tumor necrosis factor-α and fever after peripheral inflammation in the rat. Am J Physiol 1994;267:R1431-6.
22. Luheshi GN, Strefferl A, Turnbull AV, Dascombe MJ, Brouwer S, Hopkins SJ, et al. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-α in the rat. Am J Physiol 1997;272:R862-8.
23. Khan M, Griebel R. Acute spinal cord injury in the rat: comparison of three experimental techniques. Can J Neurol Sci 1983;10: 161-5.
24. Kozak W, Conn CA, Kluger MJ. Lipopolysaccharide induces fever and depressed locomotor activity in unrestrained mice. Am J Physiol 1994;266:R125-35.
25. Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997;40:1670-9.
26. Gegout P, Gillet P, Chevrier D, Guingamp C, Terlain B, Netter P. Characterization of zymosan-induced arthritis in the rat: effects on joint inflammation and cartilage metabolism. Life Sci 1994;55: PL321-6.
27. Philippe L, Gegout-Pottie P, Guingamp C, Bordji K, Terlain B, Netter P, et al. Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol 1997;273:R1550-6.
28. Van den Berg WB, Kruijsen MWM, van de Putte LBA. The mouse patella assay. Rheumatol Int 1982;1:165-9.
29. Khiri H, Reynier P, Peyrol N, Lerique B, Torresani J, Plannels R. Quantitative multistandard RT-PCR assay using interspecies polymorphism. Mol Cell Probes 1996;10:201-11.
30. Louis SM, Russell NJW, Jamieson A, Dockray GJ. The role of calcitonin gene-related peptide (CGRP) and substance P (SP) in neurogenic inflammatory responses in the rat [abstract]. Regul Pept 1988;22:416.
31. Louis SM, Johnstone D, Millest AJ, Russell NJW, Dockray GJ. Immunization with calcitonin gene-related peptide reduces the inflammatory response to adjuvant arthritis in the rat. Neuroscience 1990;39:727-31.
32. Oaklander AL, Romans K, Horasek S, Stocks A, Hauer P, Meyer RA. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol 1998;44:789-95.
33. Bowden JJ, Garland AM, Balik P, Lefevre P, Grady EF, Vigna SR, et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci U S A 1994;91:8964-8.
34. Jansco N, Jansco-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 1967;31:138-51.
35. Scott DT, Lam FY, Ferrell WR. Acute inflammation enhances substance P-induced plasma protein extravasation in the rat knee joint. Regul Pept 1992;39:227-35.
36. Lombard MC, Weil-Fugazza J, Ries C, Allard M. Unilateral joint inflammation induces bilateral and time-dependent changes in neuropeptide FF binding in the superficial dorsal horn of the rat spinal cord: implication of supraspinal descending systems. Brain Res 1999;816:598-608.
37. Grubb BD. Peripheral and central mechanisms of pain. Br J Anaesth 1998;81:8-11.
38. Lanteri-Minet M, De Pommery J, Herdegen T, Weil-Fugazza J, Bravo R, Menerey D. Differential time course and spatial expression of Fos, Jun and Krox-24 proteins in spinal cord of rats undergoing subacute or chronic somatic inflammation. J Comp Neurol 1993;333:223-35.
39. Buritova J, Honore P, Besson JM. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat. Pain 1996;67: 379-89.
40. Lennie TA, McCarthy DO, Keesey RE. Body energy status and the metabolic response to acute inflammation. Am J Physiol 1995;269:R1024-31.
41. Lewis EJ, Bishop J, Aspinall SJ. A simple inflammation model that distinguishes between the actions of anti-inflammatory and antirheumatic drugs. Inflamm Res 1998;47:26-35.
42. Laduron P. L'inflammation neurogénique. In: Russo-Marie F, Peltier A, Polla BS, editors. L'inflammation. Paris: John Libbey; 1998. p. 172-85.
43. O'Byrne EM, Blancuzzi V, Wilson DE, Wong M, Jeng AY. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 1990;33:1023-8.
44. Ma QP, Woolf CJ. Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the rat. Pain 1996;67: 307-16.
45. Levine JD, Dardick AJ, Roizen MF, Helms C, Basbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986;6:3423-9.
46. Aanonsen LM, Wilcox GL. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther 1987;243:9-19.
47. Liu H, Manthy PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997;386:721-4.
48. Liu X, André D, Puizillout J-J. Substance P post-synaptically potentiates glutamate-induced currents in dorsal vagal neurons. Brain Res 1998;804:95-104.
49. Schaible HG, Grubb BD. Afferent and spinal mechanisms of joint pain. Pain 1993;55:5-54.
50. Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, et al. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum 1994;37:965-82.
51. Bileviciute I, Stenfors C, Theodorsson E, Lundeberg T. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral edema formation and release of CGRP-like immunoreactivity in the rat hindpaw. Br J Pharmacol 1998;125:1304-12.